Long-Term Impact of Belimumab on Health-Related Quality of Life and Fatigue in Patients With Systemic Lupus Erythematosus: Six Years of Treatment.

Arthritis Care Res (Hoboken) · 2019 · PMC6593666 · PMID 30320964

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

A strong trend between baseline glucocorticoid dosage categories (none, <7.5, or ≥7.5 mg/day) and each yearly time point was not identified.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.